[Review of North American studies on nedocromil sodium].
Nedocromil sodium is a new prophylactic antiasthmatic medication. Its therapeutic profile is close to sodium cromoglycate but its antiinflammatory properties seem to be superior. North-American studies on this medication have shown that this preparation can inhibit the bronchial response to exercise, inhalation of cold air and to antigens. It can replace theophyllines and is a useful preparation in asthmatic subjects requiring several medications to control asthma in improving the control of asthma and reducing the need for bronchodilators. Nedocromil sodium allows for a reduction in the doses of oral steroids in some severe asthmatic subjects. Side effects are infrequent, minor and mainly consist in a feeling of bad taste.